Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Pharmacy and Pharmacognosy Research is Scopus-indexed (Q2, CiteScore 2.5), WoS ESCI, DOAJ. Published by Academic Association of Pharmaceutical Sciences from Antofagasta (ASOCIFA).
Checked against the index lists dated .
ISSN 0719-4250Verify ISSN ↗
Publisher: Academic Association of Pharmaceutical Sciences from Antofagasta (ASOCIFA)
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacy | 18 / 52 | 66th | Q2 |
| Complementary and Alternative Medicine | 52 / 115 | 55th | Q2 |
| Pharmaceutical Science | 109 / 191 | 43rd | Q3 |
| Pharmacology | 233 / 328 | 29th | Q3 |
| Drug Discovery | 122 / 161 | 24th | Q4 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2013–present, best quartile Q2, CiteScore 2.5.
Journal of Pharmacy and Pharmacognosy Research is Q2 in Pharmacy (rank 18 of 52), Q2 in Complementary and Alternative Medicine (rank 52 of 115) and Q3 in Pharmaceutical Science (rank 109 of 191), by CiteScore 2025. It is ranked in 5 subject areas in all.
Journal of Pharmacy and Pharmacognosy Research is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.5, which places it in quartile Q2 at the 66th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.271, quartile Q3, with an H-index of 25.
Journal of Pharmacy and Pharmacognosy Research is published by Academic Association of Pharmaceutical Sciences from Antofagasta (ASOCIFA). Its ISSN is 0719-4250.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Journal of Pharmacy and Pharmacognosy Research has an h-index of 27 and a 2-year mean of 1.02 citations per paper (OpenAlex). Its Scopus CiteScore is 2.5, quartile Q2. On 2-year citations it ranks #19 of 50 Scopus journals in Pharmacy.
Journal of Pharmacy and Pharmacognosy Research published 126 papers in 2025; its busiest recent year was 2024 with 155. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 91 research articles (2025–2026), authors are most often from Indonesia (59.2%), Vietnam (8.2%) and Saudi Arabia (3.2%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.